FDAnews
www.fdanews.com/articles/189497-fda-oks-mobile-app-for-assisting-opioid-use-disorder-treatments
AppPhone.gif

FDA OK’s Mobile App for Assisting Opioid Use Disorder Treatments

December 11, 2018

The FDA granted 510(k) clearance for Pear Therapeutics’ reSET-O, an app designed to help patients with opioid use disorder stick with their recovery programs.

The app is meant to be used with buprenorphine and contingency management, a behavior modification therapy.

After receiving a doctor’s prescription for the app, it can be downloaded onto a mobile device for use with active participation in an opioid use disorder treatment program. It serves as a training, monitoring and reminder tool for patients and healthcare providers.

View today's stories